|
What to Fight for When Negotiating Payment for Research-Related Injuries
Sites should demand that clinical trial agreements and informed consent documents clearly state that the sponsor will cover the cost of treatment for an injury caused by an investigational drug or device upfront — not after a site doles out money or bills a patient’s insurance, site experts say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives